Lilly Asia Ventures

Lilly Asia Ventures (LAV) is a Shanghai, China–headquartered biomedical venture capital firm founded in 2008 that makes early- to growth-stage investments in life sciences and healthcare companies, with a primary focus on biopharmaceuticals, therapeutics, medical devices and diagnostics across Asia and selective global markets. It originated as a corporate venture arm of Eli Lilly before spinning out as an independent investor and manages multiple funds with institutional commitments to support innovative healthcare technologies. LAV maintains offices in Shanghai, Hong Kong and Palo Alto, deploying strategic capital alongside operational support to help portfolio companies advance science toward commercial and clinical outcomes.